Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (REEF)
This study is ongoing, but not recruiting participants.
Study NCT01292798   Information provided by California Retina Consultants

First Received on February 7, 2011.   Last Updated on December 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Macular Edema
Additional conditions recognized in this trial
Edema
Macular Edema
More general conditions related to this trial
Eye Diseases
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Interventions listed in this trial
Ranibizumab
Sponsors listed in this trial
California Retina Consultants
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services